Metabolic effects of polycystic ovary syndrome in adolescents

논문상세정보
' Metabolic effects of polycystic ovary syndrome in adolescents' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 부인과, 산과학, 소아과학
  • insulin resistance
  • metabolic syndrome
  • polycystic ovary syndrome
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,016 0

0.0%

' Metabolic effects of polycystic ovary syndrome in adolescents' 의 참고문헌

  • 서울지역 여자대학생에서 다낭성난소증후군의 유병률
    변은경 Endocrinology and Metabolism 20 2 120-126 [2005]
  • The metabolic syndrome in young Korean women with polycystic ovary syndrome
    Park HR Diabetes Res Clin Pract 77 Suppl 1 S243-S246 [2007]
  • The importance of diagnosing the polycystic ovary syndrome
    Lobo RA Ann Intern Med 132 989-993 [2000]
  • The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women
    Pasquali R Clin Endocrinol (Oxf) 39 1-16 [1993]
  • The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study
    Orio F Jr J Clin Endocrinol Metab 89 3696-3701 [2004]
  • Smaller LDL particle size in women with polycystic ovary syndrome compared to controls
    Dejager S Clin Endocrinol (Oxf) 54 455-462 [2001]
  • Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome
    Grulet H Clin Endocrinol (Oxf) 38 621-626 [1993]
  • Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
  • Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome
    Norman RJ Hum Reprod 16 1995-1998 [2001]
  • Relationship between insulin resistance and abnormal lipid profile in obese adolescents
    Steinberger J J Pediatr 126 690-695 [1995]
  • Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome
    Berria R Clin Pharmacol Ther 80 105-114 [2006]
  • Recommendations to prevent and control iron deficiency in the United States
    Yip R MMWR Recomm Rep i-29- [1998]
  • Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study
    Knochenhauer ES J Clin Endocrinol Metab 83 3078-3082 [1998]
  • Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women
    Legro RS J Clin Endocrinol Metab 84 165-169 [1999]
  • Polycystic ovary syndrome
    Zawadzki JK 377-384 [1992]
  • Pathophysiology and types of dyslipidemia in PCOS
    Diamanti-Kandarakis E Trends Endocrinol Metab 18 280-285 [2007]
  • Obesity and lipid profiles in children and adolescents
    Friedland O J Pediatr Endocrinol Metab 15 1011-1016 [2002]
  • Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome
    Wild RA J Clin Endocrinol Metab 61 946-951 [1985]
  • Insulin dynamics in young women with polycystic ovary syndrome and normal glucose tolerance across categories of body mass index
    Manco M PloS One 9 e92995- [2014]
  • Insulin action in the polycystic ovary syndrome
    Dunaif A. Endocrinol Metab Clin North Am 28 341-359 [1999]
  • Insulin Resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis
    Dunaif A. Endocr Rev 18 774-800 [1997]
  • Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome
    Glueck CJ Metabolism 52 908-915 [2003]
  • In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls
    Economou F Hormones (Athens) 8 199-206 [2009]
  • Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome
    Sozen I Obstet Gynecol Surv 55 321-328 [2000]
  • Gynecological care in young women: a high-risk period of life
    Bitzer J Gynecol Endocrinol 30 542-548 [2014]
  • Glucose intolerance in obese adolescents with polycystic ovary syndrome:roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease
    Arslanian SA J Clin Endocrinol Metab 86 66-71 [2001]
  • Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)
  • Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society
    Escobar-Morreale HF Hum Reprod Update 18 146-170 [2012]
  • Effects of graded doses of testosterone on erythropoiesis in healthy young and older men
    Coviello AD J Clin Endocrinol Metab 93 914-919 [2008]
  • Effect of obesity on coriversion of plasma androstenedione to estrone in ovulatory and anovulatory young women
    Edman CD Am J Obstet Gynecol 130 456-461 [1978]
  • Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS):comparison between nonobese and obese adolescents
    Silfen ME J Clin Endocrinol Metab 88 4682-4688 [2003]
  • Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline
    Legro RS J Clin Endocrinol Metab 98 4565-4592 [2013]
  • Correlation Between Iron Status Parameters and Hormone Levels in Women with Polycystic Ovary Syndrome
    Al-Hakeim HK. Clin Med Insights Womens Health 5 1-8 [2012]
  • Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women
    Chae SJ Hum Reprod 23 1924-1931 [2008]
  • Cardiovascular risk in adolescent and young adult obese females with polycystic ovary syndrome (PCOS)
    Macut D J Pediatr Endocrinol Metab 14 Suppl 5 1353-1359 [2001]
  • Body iron status and association with hyperinsulinaemia and hyperandrogenism in non-obese Indian women with polycystic ovarian syndrome
    Supriya P J Clin Sci Res 1 2-7 [2012]
  • Androgen and erythropoiesis:evidence for an androgen receptor in erythroblasts from human bone marrow cultures
    Claustres M Horm Res 29 17-22 [1988]
  • Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance
    Coviello AD J Clin Endocrinol Metab 91 492-497 [2006]
  • A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome
    Nestler JE J Clin Endocrinol Metab 72 83-89 [1991]
  • A critical evaluation of simple methods for the estimation of free testosterone in serum
    Vermeulen A J Clin Endocrinol Metab 84 3666-3672 [1999]